| Obesity and cancer risk: Emerging biological mechanisms and perspectives KI Avgerinos, N Spyrou, CS Mantzoros, M Dalamaga Metabolism 92, 121-135, 2019 | 1321 | 2019 |
| The role of adiponectin in cancer: a review of current evidence M Dalamaga, KN Diakopoulos, CS Mantzoros Endocrine reviews 33 (4), 547-594, 2012 | 735 | 2012 |
| Adiponectin and breast cancer risk C Mantzoros, E Petridou, N Dessypris, C Chavelas, M Dalamaga, ... The Journal of Clinical Endocrinology & Metabolism 89 (3), 1102-1107, 2004 | 727 | 2004 |
| Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals HS Moon, M Dalamaga, SY Kim, SA Polyzos, OP Hamnvik, F Magkos, ... Endocrine reviews 34 (3), 377-412, 2013 | 306 | 2013 |
| Understanding the role of the gut microbiome and microbial metabolites in obesity and obesity-associated metabolic disorders: current evidence and perspectives N Vallianou, T Stratigou, GS Christodoulatos, M Dalamaga Current obesity reports 8, 317-332, 2019 | 290 | 2019 |
| Covid-19 and disparities in nutrition and obesity MJ Belanger, MA Hill, AM Angelidi, M Dalamaga, JR Sowers, ... New England Journal of Medicine 383 (11), e69, 2020 | 266 | 2020 |
| Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives M Dalamaga, SH Chou, K Shields, P Papageorgiou, SA Polyzos, ... Cell metabolism 18 (1), 29-42, 2013 | 237 | 2013 |
| Probiotics, prebiotics, synbiotics, postbiotics, and obesity: current evidence, controversies, and perspectives N Vallianou, T Stratigou, GS Christodoulatos, C Tsigalou, M Dalamaga Current obesity reports 9, 179-192, 2020 | 198 | 2020 |
| Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives N Vallianou, GS Christodoulatos, I Karampela, D Tsilingiris, F Magkos, ... Biomolecules 12 (1), 56, 2021 | 191 | 2021 |
| Could respiratory fluoroquinolones, levofloxacin and moxifloxacin, prove to be beneficial as an adjunct treatment in COVID-19? I Karampela, M Dalamaga Archives of medical research 51 (7), 741-742, 2020 | 181 | 2020 |
| Vitamin D and obesity: current evidence and controversies I Karampela, A Sakelliou, N Vallianou, GS Christodoulatos, F Magkos, ... Current obesity reports 10, 162-180, 2021 | 169 | 2021 |
| Sarcopenic obesity: epidemiologic evidence, pathophysiology, and therapeutic perspectives C Koliaki, S Liatis, M Dalamaga, A Kokkinos Current obesity reports 8, 458-471, 2019 | 139 | 2019 |
| Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case–control study M Dalamaga, I Migdalis, JL Fargnoli, E Papadavid, E Bloom, N Mitsiades, ... Cancer Causes & Control 20, 625-633, 2009 | 138 | 2009 |
| Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case–control study M Dalamaga, K Karmaniolas, A Panagiotou, A Hsi, J Chamberland, ... Cancer Causes & Control 20, 193-199, 2009 | 121 | 2009 |
| Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters M Dalamaga, G Sotiropoulos, K Karmaniolas, N Pelekanos, E Papadavid, ... Clinical biochemistry 46 (7-8), 584-590, 2013 | 116 | 2013 |
| Update on the obesity epidemic: after the sudden rise, is the upward trajectory beginning to flatten? C Koliaki, M Dalamaga, S Liatis Current Obesity Reports 12 (4), 514-527, 2023 | 112 | 2023 |
| Deciphering the association between psoriasis and obesity: current evidence and treatment considerations K Paroutoglou, E Papadavid, GS Christodoulatos, M Dalamaga Current obesity reports 9, 165-178, 2020 | 101 | 2020 |
| Obesity, insulin resistance, adipocytokines and breast cancer: new biomarkers and attractive therapeutic targets M Dalamaga World journal of experimental medicine 3 (3), 34, 2013 | 98 | 2013 |
| The role of adipokines in breast cancer: current evidence and perspectives GS Christodoulatos, N Spyrou, J Kadillari, S Psallida, M Dalamaga Current obesity reports 8, 413-433, 2019 | 90 | 2019 |
| Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens? M Dalamaga, I Karampela, CS Mantzoros Metabolism 108, 154260, 2020 | 87 | 2020 |
